Trial intelligence / Profile preview

Ropivacaine and ketorolac for pain after total hip arthroplasty

NCT01344395Phase 4Completed

Sponsor
Aarhus University
Start
Mar 2010
Primary completion
Jun 2011
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection, ketorolac in postoperative pain, sponsored by Aarhus University. Started Mar 2010; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injectionketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01344395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01344395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call